Literature DB >> 14504876

Bone remodeling and bone mineral density during pregnancy.

U Ulrich1, P B Miller, D R Eyre, C H Chesnut, H Schlebusch, M R Soules.   

Abstract

INTRODUCTION: The effect of pregnancy upon the maternal skeleton is not fully understood. The information that has been gathered by recent studies is conflicting with regard to overall loss or gain of bone during pregnancy. The aim of the present longitudinal, controlled study, therefore, was to investigate the effect of pregnancy on lumbar spine, wrist, and hip bone mineral density, and to describe bone remodeling during pregnancy as indicated by biochemical markers of both bone resorption and formation.
MATERIALS AND METHODS: Thirty healthy women (15 subjects seeking pregnancy and 15 non-pregnant controls) were studied. Bone mineral density (BMD) was measured by dual-energy x-ray absorptiometry before conception and within 2 weeks after parturition. Markers of bone resorption (urinary cross-linked type I collagen N-telopeptides, serum type I collagen C-telopeptides) and bone formation (total and bone specific alkaline phosphatase, osteocalcin), and total serum calcium were analyzed before, during (once in each trimester), and after pregnancy.
RESULTS: During pregnancy, BMD decreased significantly by 3.4+/-4.1% at the lumbar spine and 4.3+/-3.9% at the trochanter, while there was a slight but significant increase in BMD at the proximal 1/3 of the forearm (1.3+/-1.9%). Total hip and femoral neck BMD did not change significantly, nor did total and ultradistal forearm BMD. Bone resorption increased during pregnancy with peak levels in the third trimester (N-telopeptides) or post partum (C-telopeptides), respectively. The increase in bone resorption was accompanied by a significant decrease in serum calcium in the third trimester. Markers of bone formation showed a biphasic pattern with decreases from baseline to the first (total and bone specific alkaline phosphatase) or second trimester (osteocalcin), respectively, followed by a significant increase in the third trimester and post partum. There was no change in any parameter in the control group throughout the study.
CONCLUSION: In conclusion, pregnancy is characterized by high bone turnover with resorption preceding formation. During the first and second trimester bone remodeling is uncoupled. Serum calcium decreases as bone resorption peaks in late pregnancy. There are significant decreases in bone mineral density at sites rich in trabecular bone, such as the lumbar spine and the trochanter.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14504876     DOI: 10.1007/s00404-002-0410-8

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  18 in total

1.  Association between prolonged breastfeeding and bone mineral density and osteoporosis in postmenopausal women: KNHANES 2010-2011.

Authors:  I R Hwang; Y K Choi; W K Lee; J G Kim; I K Lee; S W Kim; K G Park
Journal:  Osteoporos Int       Date:  2015-09-15       Impact factor: 4.507

2.  Changes in bone mineral density and body composition during pregnancy and postpartum. A controlled cohort study.

Authors:  U K Møller; S Við Streym; L Mosekilde; L Rejnmark
Journal:  Osteoporos Int       Date:  2011-05-25       Impact factor: 4.507

3.  Effect of prenatal calcium supplementation on bone during pregnancy and 1 y postpartum.

Authors:  Andrea Cullers; Janet C King; Marta Van Loan; Ginny Gildengorin; Ellen B Fung
Journal:  Am J Clin Nutr       Date:  2019-01-01       Impact factor: 7.045

4.  A longitudinal study of the effect of heparin thromboprophylaxis during pregnancy on maternal bone metabolism.

Authors:  O Ogueh; M R Johnson; A Benjamin
Journal:  Obstet Med       Date:  2009-11-30

5.  Increase in accumulation of strontium-90 in the maternal skeleton during pregnancy and lactation: analysis of the Techa River data.

Authors:  Evgenia I Tolstykh; Natalia B Shagina; Marina O Degteva
Journal:  Radiat Environ Biophys       Date:  2014-05-27       Impact factor: 1.925

6.  Lactation is associated with greater maternal bone size and bone strength later in life.

Authors:  P K Wiklund; L Xu; Q Wang; T Mikkola; A Lyytikäinen; E Völgyi; E Munukka; S M Cheng; M Alen; S Keinänen-Kiukaanniemi; S Cheng
Journal:  Osteoporos Int       Date:  2011-09-17       Impact factor: 4.507

7.  Postpartum osteoporosis and vertebral fractures in two patients treated with enoxaparin during pregnancy.

Authors:  D Ozdemir; A A Tam; A Dirikoc; R Ersoy; B Cakir
Journal:  Osteoporos Int       Date:  2014-08-20       Impact factor: 4.507

8.  Osteocalcin, under-carboxylated osteocalcin and osteopontin are not associated with gestational diabetes mellitus but are inversely associated with leptin in non-diabetic women.

Authors:  R Saucedo; G Rico; G Vega; L Basurto; L Cordova; R Galvan; M Hernandez; E Puello; A Zarate
Journal:  J Endocrinol Invest       Date:  2014-12-06       Impact factor: 4.256

9.  Maternal vitamin D biomarkers are associated with maternal and fetal bone turnover among pregnant women consuming controlled amounts of vitamin D, calcium, and phosphorus.

Authors:  Heyjun Park; Patsy M Brannon; Allyson A West; Jian Yan; Xinyin Jiang; Cydne A Perry; Olga Malysheva; Saurabh Mehta; Marie A Caudill
Journal:  Bone       Date:  2016-12-08       Impact factor: 4.398

10.  Undercarboxylated osteocalcin is associated with insulin resistance, but not adiponectin, during pregnancy.

Authors:  Panudda Srichomkwun; Natnicha Houngngam; Sophitsachi Pasatrat; Thipaporn Tharavanij; Lalita Wattanachanya; Weerapan Khovidhunkit
Journal:  Endocrine       Date:  2015-12-26       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.